YS Biopharma Co., Ltd.

NasdaqCM:YS Stock Report

Market Cap: US$145.5m

YS Biopharma Management

Management criteria checks 0/4

YS Biopharma's CEO is David Shao, appointed in Mar 2023, has a tenure of 1.17 years. directly owns 1.09% of the company’s shares, worth $1.58M. The average tenure of the management team and the board of directors is 1.2 years and 0.3 years respectively.

Key information

David Shao

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.2yrs
CEO ownership1.1%
Management average tenure1.2yrs
Board average tenureless than a year

Recent management updates

Recent updates


CEO

David Shao (55 yo)

1.2yrs

Tenure

Dr. Hui Shao, also known as David, Ph D served as Senior Vice President of Finance at China Aoxing Pharmaceutical Co. Inc. from January 4, 2007 to 2010. Dr. Shao was responsible for all its financial and a...


Leadership Team

NamePositionTenureCompensationOwnership
Gang Li
Head of Marketing & Sales1.2yrsno datano data
Yuan Liu
Head of Vaccine Research1.2yrsno datano data
Hui Shao
President1.2yrsno data1.09%
CN¥ 1.6m
Chunyuan Wu
Chief Financial Officer & Directorless than a yearno data0.052%
CN¥ 75.3k
Zenaida Reynoso Mojares
Chief Medical Officer1.2yrsno datano data

1.2yrs

Average Tenure

45yo

Average Age

Experienced Management: YS's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hui Shao
President1.2yrsno data1.09%
CN¥ 1.6m
Chunyuan Wu
Chief Financial Officer & Directorless than a yearno data0.052%
CN¥ 75.3k
Viren Mehta
Independent Director1.2yrsno data0.038%
CN¥ 56.0k
Ajit S. Shetty
Independent Chairman1.2yrsno data0.046%
CN¥ 66.6k
Rui Yu
Independent Directorless than a yearno datano data
Haitao Zhao
Directorless than a yearno datano data
Pierson Pan
Directorless than a yearno datano data
Jin Wang
Directorless than a yearno datano data
Yuntao Cui
Directorless than a yearno datano data
Henry Chen
Directorless than a yearno datano data

0.3yrs

Average Tenure

55yo

Average Age

Experienced Board: YS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.